{"SPADE_UN_11618": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_11618", "Peptide Name": "[Pro3,DLeu9]TL(1) (Temporin L peptide derivative)", "Source": "Synthetic construct", "Family": "Derived from Temporin L", "Gene": "Not found", "Sequence": "FVPWFSKFLGRIL", "Sequence Length": 13, "UniProt Entry": "No entry found", "Protein Existence": "Synthetic", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-"], "Target Organism": "[Ref.28863356] Gram-positive bacteria:Bacillus megaterium Bm11 (MIC=3.125μM), Staphylococcus aureus Cowan I (MIC=12.5μM), Staphylococcus epidermidis ATCC 12228 (MIC=6.25μM);Gram-negative bacteria:Acinetobacter baumannii ATCC 19606 (MIC=12.5μM), Escherichia coli D21 (MIC=12.5μM), Pseudomonas syringae pv tabaci 1918 (MIC=12.5μM), Pseudomonas aeruginosa ATCC 2785 (MIC=50μM);Yeasts:Candida albicans ATCC 10231 (MIC=3.125μM), Candida crusei ATCC 6258 (3.125μM).", "Hemolytic Activity": "[Ref.28863356] 21±4% hemolysis at 50μM, 7±3% hemolysis at 25μM, 6±3% hemolysis at 12.5μM, 3±2% hemolysis at 6.25μM, 1±1%  hemolysis at 3.125μM against human red blood cells.20.63 ± 2.66% cytotoxic effect at 12.5μM, 57.52 ± 3.99%  cytotoxic effect at 25μM, 91.58 ± 3.85% cytotoxic effect at 50 μM on HaCaT cells.", "Cytotoxicity": "[Ref.28863356] The cytotoxic effects of the peptide are 20.63±2.66%, 57.52±3.99% and 91.58±3.85% at 12.5, 25 and 50 μM", "Binding Target": "Not found", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "Mixed (D-Leu9)", "Structure Description": "The analogues bearing a D residue shows a reduction in the percentage of helicity compared to the corresponding L analogues in the MMs", "Formula": "C83H120N18O15", "Mass": 1609.95, "PI": 11.0, "Net Charge": 2, "Hydrophobicity": 0.97, "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min", "Function": "Antimicrobial activity against the Gram-negative bacteria, Gram-positive bacteria and Fungi. The position 9 of [Pro3,DLeu9]TL(1) is D-Leucine.", "Literature": [{"Title": "Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue Evaluation of antimicrobial, cytotoxic and hemolytic activities", "Pubmed ID": "28863356", "Reference": "Eur J Med Chem. 2017 Oct 20;139750-761.", "Author": "Merlino F, Carotenuto A, Casciaro B, Martora F, Loffredo MR, Di Grazia A, Yousif AM, Brancaccio D, Palomba L, Novellino E, Galdiero M, Iovene MR, Mangoni ML, Grieco P.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=28863356"}], "Frequent Amino Acids": "FLG", "Absent Amino Acids": "ACDEHMNOQTUY", "Basic Residues": 2, "Acidic Residues": 0, "Hydrophobic Residues": 9, "Polar Residues": 4, "Positive Residues": 2, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_14145", "Similarity": 1.0, "Sequence": "FVPWFSKFLGRIL"}, {"SPADE_ID": "SPADE_UN_14148", "Similarity": 1.0, "Sequence": "FVPWFSKFLRIL"}, {"SPADE_ID": "SPADE_UN_14149", "Similarity": 1.0, "Sequence": "FVPWFSKFLRIL"}]}}}